Reprogramming the Genetic Code
Event Details
- Type
- Friday Lecture Series
- Speaker(s)
-
Jason Chin, Ph.D., professor of chemistry & chemical biology, department of chemistry, University of Cambridge; programme leader, division of protein & nucleic acid chemistry, MRC Laboratory of Molecular Biology
- Speaker bio(s)
-
In terrestrial life, DNA is copied to messenger RNA, and the 64 triplet codons in messenger RNAs are decoded – in the process of translation – to synthesize proteins. Cellular protein translation provides the ultimate paradigm for the synthesis of long polymers of defined sequence and composition, but is commonly limited to polymerizing the 20 canonical amino acids. Dr. Jason Chin will describe his lab's progress towards the encoded synthesis of non-canonical biopolymers. These advances may form a basis for new classes of genetically encoded polymeric materials and medicines. To realize their goals the lab is re-imagining some of the most conserved features of the cell; they have created new ribosomes, new aminoacyl-tRNA synthetase/tRNA pairs, and organisms with entirely synthetic genomes in which they have re-written the genetic code.
Jason Chin is a Programme Leader at the Medical Research Council Laboratory of Molecular Biology (MRCLMB), where he is also Head of the Centre for Chemical & Synthetic Biology (CCSB). He is a Professor of Chemistry & Chemical Biology at the University of Cambridge, and holds a joint appointment at the University of Cambridge Department of Chemistry. He is also a fellow in Natural Sciences at Trinity College, Cambridge.
Jason is a native of the UK. He was an undergraduate at Oxford University, where he worked with Professor John Sutherland on Cephalosporin biosynthesis. He obtained his Ph.D, as a Fulbright awardee from Yale University, working with Professor Alanna Schepartz. He was a Damon Runyon Fellow at The Scripps Research Institute with Professor Peter Schultz where he developed the first approaches to systematically expand the genetic code of eukaryotic cells and pioneered approaches, that are now widely used, for defining protein interactions by genetically encoding photocrosslinking amino acids.
Jason’s work has been recognized by a number of awards, including: the Francis Crick Prize (Royal Society), the Corday Morgan Prize (Royal Society of Chemistry), European Molecular Biology Organization’s (EMBO) Gold Medal, Louis-Jeantet Young Investigator Career Award, Sackler International Prize in the Physical Science. He is in the European Inventors Hall of Fame, a member of EMBO, a Fellow of the Academy of Medical Sciences, and a Fellow of The Royal Society. Jason’s early work provided a foundation for Ambrx and he is the founder and CSO of Constructive Bio. He is also a non-executive director at the UK Government’s Department of Science, Innovation and Technology.
- Open to
- Tri-Institutional